Neurofeedback for Head and Neck Cancer Pain
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you must not change your type of pain medication during the study. You cannot participate if you are taking antipsychotic medications.
What data supports the effectiveness of the treatment LORETA Neurofeedback Training for head and neck cancer pain?
Is neurofeedback safe for humans?
How does LORETA Neurofeedback Training differ from other treatments for head and neck cancer pain?
LORETA Neurofeedback Training is unique because it allows patients to modify their brain wave activity to reduce pain perception, unlike traditional pain treatments that often rely on medications. This approach targets specific brain areas associated with pain, offering a non-drug alternative for managing pain in head and neck cancer patients.29101112
What is the purpose of this trial?
This pilot trial studies how well neurofeedback training works in decreasing acute radiotherapy-induced pain in patients with head and neck cancer. Neurofeedback training is a type of therapy that uses electroencephalograph and a computer software program to measure brain wave activity. Neurofeedback training may help teach patients ways to modify their own brain waves to decrease the perception of pain and improve quality of life.
Research Team
Sarah Prinsloo
Principal Investigator
M.D. Anderson Cancer Center
Eligibility Criteria
This trial is for English-speaking individuals with head and neck cancer, who are about to start a 6-week radiotherapy course and currently have low pain levels. They must consent to the study's protocol and not plan on changing their pain medication during the study. Those with chronic pain, mental health conditions like bipolar disorder or schizophrenia, seizure disorders, or active brain diseases cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Radiotherapy
Patients undergo radiotherapy as part of their cancer treatment
Neurofeedback Training
Patients undergo neurofeedback training once per day, three times per week for up to 6 treatments
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- LORETA Neurofeedback Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator